Henry Schein (NASDAQ:HSIC) Raised to “Hold” at StockNews.com

Henry Schein (NASDAQ:HSIC) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Thursday.

Other equities research analysts have also issued research reports about the stock. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. lowered their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Robert W. Baird cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday. Finally, Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. One analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $77.50.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $68.00 on Thursday. Henry Schein has a 12 month low of $62.12 and a 12 month high of $82.63. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.62 billion, a PE ratio of 25.19, a price-to-earnings-growth ratio of 2.08 and a beta of 0.87. The business has a fifty day simple moving average of $70.51 and a 200-day simple moving average of $69.75.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.32 EPS. On average, sell-side analysts anticipate that Henry Schein will post 4.74 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in shares of Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after acquiring an additional 260,537 shares during the period. American Century Companies Inc. boosted its holdings in Henry Schein by 3.1% in the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after purchasing an additional 162,477 shares during the period. Swedbank AB acquired a new stake in Henry Schein in the 1st quarter worth $215,998,000. Nuance Investments LLC grew its position in Henry Schein by 22.3% in the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after purchasing an additional 414,748 shares during the last quarter. Finally, Burgundy Asset Management Ltd. increased its holdings in shares of Henry Schein by 1.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock worth $105,148,000 after purchasing an additional 16,476 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.